Alkem Laboratories Limited (ALKEM) - Total Liabilities
Based on the latest financial reports, Alkem Laboratories Limited (ALKEM) has total liabilities worth Rs64.77 Billion INR (≈ $700.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ALKEM operating cash flow to assess how effectively this company generates cash.
Alkem Laboratories Limited - Total Liabilities Trend (2010–2025)
This chart illustrates how Alkem Laboratories Limited's total liabilities have evolved over time, based on quarterly financial data. Check ALKEM asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Alkem Laboratories Limited Competitors by Total Liabilities
The table below lists competitors of Alkem Laboratories Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Paramount Global Class B
NASDAQ:PARA
|
USA | $27.82 Billion |
|
Xinjiang Daqo New Energy Co Ltd
SHG:688303
|
China | CN¥3.49 Billion |
|
Amdocs Ltd
NASDAQ:DOX
|
USA | $2.88 Billion |
|
Qingdao Port International Co Ltd
SHG:601298
|
China | CN¥16.14 Billion |
|
Kiwoom
KO:039490
|
Korea | ₩65.89 Trillion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$8.31 Billion |
|
Konfoong Materials International Co Ltd
SHE:300666
|
China | CN¥5.47 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥143.36 Billion |
Liability Composition Analysis (2010–2025)
This chart breaks down Alkem Laboratories Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALKEM market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.32 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alkem Laboratories Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alkem Laboratories Limited (2010–2025)
The table below shows the annual total liabilities of Alkem Laboratories Limited from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs52.57 Billion ≈ $568.58 Million |
+8.17% |
| 2024-03-31 | Rs48.60 Billion ≈ $525.64 Million |
+12.47% |
| 2023-03-31 | Rs43.22 Billion ≈ $467.37 Million |
-17.24% |
| 2022-03-31 | Rs52.22 Billion ≈ $564.72 Million |
+31.82% |
| 2021-03-31 | Rs39.61 Billion ≈ $428.39 Million |
+8.93% |
| 2020-03-31 | Rs36.37 Billion ≈ $393.28 Million |
+37.95% |
| 2019-03-31 | Rs26.36 Billion ≈ $285.10 Million |
-1.64% |
| 2018-03-31 | Rs26.80 Billion ≈ $289.87 Million |
+35.02% |
| 2017-03-31 | Rs19.85 Billion ≈ $214.69 Million |
+13.59% |
| 2016-03-31 | Rs17.48 Billion ≈ $189.00 Million |
-20.96% |
| 2015-03-31 | Rs22.11 Billion ≈ $239.12 Million |
+30.63% |
| 2014-03-31 | Rs16.93 Billion ≈ $183.05 Million |
+1.09% |
| 2013-03-31 | Rs16.74 Billion ≈ $181.07 Million |
+31.13% |
| 2012-03-31 | Rs12.77 Billion ≈ $138.09 Million |
-10.20% |
| 2011-03-31 | Rs14.22 Billion ≈ $153.77 Million |
+301.65% |
| 2010-03-31 | Rs3.54 Billion ≈ $38.29 Million |
-- |
About Alkem Laboratories Limited
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective… Read more